These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36575780)

  • 1. [Guidelines for clinical diagnosis and treatment of advanced breast cancer in China (2022 edition)].
    ; ;
    Zhonghua Zhong Liu Za Zhi; 2022 Dec; 44(12):1262-1287. PubMed ID: 36575780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Guidelines for clinical diagnosis and treatment of advanced breast cancer in China (2020 Edition)].
    ; ;
    Zhonghua Zhong Liu Za Zhi; 2020 Oct; 42(10):781-797. PubMed ID: 33113619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chinese expert consensus on the clinical diagnosis and treatment of advanced breast carcinoma(2018)].
    Chinese Anti-Cancer Association, Committee of Breast Cancer Society
    Zhonghua Zhong Liu Za Zhi; 2018 Sep; 40(9):703-713. PubMed ID: 30293398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chinese expert consensus on the clinical diagnosis and treatment of advanced breast cancer (2018).
    Xu B; Hu X; Feng J; Geng C; Jin F; Li H; Li M; Li Q; Liao N; Liu D; Liu J; Liu Q; Lu J; Liu Z; Ma F; Ouyang Q; Pan Y; Shen K; Sun T; Teng Y; Tong Z; Wang B; Wang H; Wang S; Wang S; Wang T; Wang X; Wang X; Wang Y; Wang Z; Wu J; Yan M; Yang J; Yin Y; Yuan P; Zhang J; Zhang P; Zhang Q; Zheng H
    Cancer; 2020 Aug; 126 Suppl 16():3867-3882. PubMed ID: 32710660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Guidelines for clinical application of platinum drugs in breast cancer (2023 edition)].
    Breast Cancer Group, Branch of Oncologist, Chinese Medical Doctor Association
    Zhonghua Zhong Liu Za Zhi; 2023 Dec; 45(12):1018-1031. PubMed ID: 38110310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Guideline for the management path and quality control of breast cancer prevention and treatment in China's counties (2023 edition)].
    ;
    Zhonghua Zhong Liu Za Zhi; 2024 Jan; 46(1):1-18. PubMed ID: 38246777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Consensus of Chinese experts on hot issues in genetic testing of advanced breast cancer (2021 edition)].
    ;
    Zhonghua Zhong Liu Za Zhi; 2022 Jan; 44(1):60-67. PubMed ID: 35073649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expert consensus on the diagnosis and treatment of young breast cancer in China (2022 Edition)].
    ; ;
    Zhonghua Yi Xue Za Zhi; 2023 Feb; 103(6):387-403. PubMed ID: 36775264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chinese expert consensus on diagnosis of early lung cancer (2023 Edition)].
    Chinese Thoracic Society
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Jan; 46(1):1-18. PubMed ID: 36617923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Guidelines for clinical diagnosis and treatment of advanced triple negative breast cancer in China（2024 edition）].
    ; ;
    Zhonghua Zhong Liu Za Zhi; 2024 Mar; 46(0):471-480. PubMed ID: 38527739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comprehensive management guideline for breast cancer follow-up and healthcare (2022 edition)].
    ;
    Zhonghua Zhong Liu Za Zhi; 2022 Jan; 44(1):1-28. PubMed ID: 35073646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chinese Protocol of Diagnosis and Treatment of Colorectal Cancer (2023 edition)].
    ;
    Zhonghua Wai Ke Za Zhi; 2023 Aug; 61(8):617-644. PubMed ID: 37400205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [China clinical practice guideline for stage Ⅳ primary lung cancer (2024 edition)].
    ;
    Zhonghua Zhong Liu Za Zhi; 2024 Jul; 46(7):595-636. PubMed ID: 39034799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fulvestrant for hormone-sensitive metastatic breast cancer.
    Lee CI; Goodwin A; Wilcken N
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD011093. PubMed ID: 28043088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [China guideline for the screening and early detection of female breast cancer(2021, Beijing)].
    He J; Chen WQ; Li N; Shen HB; Li J; Wang Y; Li J; Tian JH; Zhou BS; ; ;
    Zhonghua Zhong Liu Za Zhi; 2021 Apr; 43(4):357-382. PubMed ID: 33902200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant Chemotherapy Creates Surgery Opportunities For Inoperable Locally Advanced Breast Cancer.
    Wang M; Hou L; Chen M; Zhou Y; Liang Y; Wang S; Jiang J; Zhang Y
    Sci Rep; 2017 Mar; 7():44673. PubMed ID: 28327615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impact and clinical value of the revised 2019 Chinese HER-2 testing guidelines on the detect result evaluation of invasive breast cancer cases with equivocal HER-2 immunostaining by using fluorescence in situ hybridization].
    Zhang L; Wang WW; Jiang GZ; Zhang YP
    Zhonghua Zhong Liu Za Zhi; 2021 Aug; 43(8):833-837. PubMed ID: 34407587
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chinese Protocol of Diagnosis and Treatment of Colorectal Cancer (2020 edition)].
    National Health Commission of the People's Republic of China
    Zhonghua Wai Ke Za Zhi; 2020 Aug; 58(8):561-585. PubMed ID: 32727186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparities of Trastuzumab Use in Resource-Limited or Resource-Abundant Regions and Its Survival Benefit on HER2 Positive Breast Cancer: A Real-World Study from China.
    Li J; Wang S; Wang Y; Wang X; Wang H; Feng J; Zhang Q; Sun T; Ouyang Q; Yin Y; Liu Y; Geng C; Yan M; Jiang Z
    Oncologist; 2017 Nov; 22(11):1333-1338. PubMed ID: 28798274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.